EMAIL THIS PAGE TO A FRIEND

International journal of pharmaceutics

Next generation of buccadhesive excipient: Preactivated carboxymethyl cellulose.


PMID 26773600

Abstract

Assessment of preactivated carboxymethyl cellulose as potential excipient for buccal drug delivery. Firstly, carboxymethyl cellulose (CMC) and cysteine (SH) were covalently coupled via amide bond formation to obtain thiolated carboxymethyl cellulose (CMC-SH). Further, preactivated carboxymethyl cellulose (CMC-S-S-MNA) was obtained by preactivation with 2-mercaptonicotinic acid (MNA). Sulforhodamine 101 (SRH101) was used as a model drug for permeation study through buccal mucosa. CMC-S-S-MNA was evaluated with respect to mucoadhesive and permeation enhancing effect and cytotoxicity. Thiolated carboxymethyl cellulose exhibited a total amount of 112.46 ± 0.46 thiol groups. CMC-S-S-MNA exhibited around 50% of preactivated thiol groups. The preactivated polymer showed no toxic effect. Furthermore, compared to unmodified CMC, CMC-S-S-MNA revealed 3.0-fold improved mucoadhesive properties according to the rotating cylinder method and 8.8-fold enhancement in mucoadhesiveness by tensile assay, respectively. Preactivated carboxymethyl cellulose fulfills the requirements as potential excipient of being mucoadhesive and permeation enhancing for the buccal drug delivery.

Related Materials

Product #

Image

Description

Molecular Formula

Add to Cart

419702
2-Mercaptopyridine-3-carboxylic acid, technical grade
C6H5NO2S
S7635
Sulforhodamine 101
C31H30N2O7S2